Abstract
98P Short-course radiotherapy based total neoadjuvant therapy combined with tislelizumab in the treatment of locally advanced rectal cancer: Mid-term report of a phase II, open-label, randomized controlled trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have